AbeonaBio

@AbeonaBio

Abeona Therapeutics (Nasdaq: ABEO) is a fully-integrated gene and cell therapy company at the forefront of the rapidly-advancing field of genetic medicine.

New York, NY + Cleveland, OH
Vrijeme pridruživanja: kolovoz 2016.

Tweetovi

Blokirali ste korisnika/cu @AbeonaBio

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AbeonaBio

  1. prije 12 sati

    Next week, we will descend upon Orlando for the WORLDSymposium™ on Lysosomal Storage Diseases. We look forward to coming together with the community to exchange scientific knowledge helping to advance our programs.

    Poništi
  2. 27. sij
    Poništi
  3. proslijedio/la je Tweet

    You’ll find that our new website is more user-friendly, while remaining a resource that the EB Community, our partners, & our supporters can count on! We're making final touches to ensure that you have access to the most up-to-date info on everything EB:

    Poništi
  4. 23. sij

    As the sun sets on EB#2020, we thank the Global EB Alliance for convening the & our hosts . We had a great experience in London discussing topics like clinical management strategies & challenges in patient care.

    Poništi
  5. 21. sij

    Many insightful and inspiring conversations here at . Join us at Stand 16 to learn more about how we are harnessing the promise of genetic medicine to advance our work in .

    Poništi
  6. 16. sij

    We are excited to be among the leaders descending upon London next week for ! The Abeona team will be represented @ Stand 16 – stop by, say hi, & learn more about our pivotal VIITALᵀᴹ study evaluating our for .

    Poništi
  7. 13. sij

    Today, we announced we have received IRB approval from Stanford University to initiate the VIITAL™ Study, our pivotal Phase 3 trial evaluating our in recessive dystrophic epidermolysis bullosa () patients. See our press release:

    Poništi
  8. 24. pro 2019.

    Abeona Announces Closing of $103.5 Million Underwritten Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares. Read our press release:

    Poništi
  9. 20. pro 2019.

    is just one month away. We look forward to joining other industry leaders dedicated to the community in London Jan. 20-23. Visit the congress website to learn more about the event:

    Poništi
  10. 20. pro 2019.

    Abeona Therapeutics Receives European Medicines Agency PRIME Designation for ABO-102 Gene Therapy in MPS IIIA. Read our press release:

    Poništi
  11. 19. pro 2019.

    Today, the 33rd Annual Family Conference kicks off at Disney World. As one of the longest standing gatherings of leaders in , the event honors community progress and provides live support for patients & families. Come visit our table and say hi!

    Poništi
  12. 16. pro 2019.

    We’re proud to be a sponsor of , the first global congress on ! Learn about our commitment to the EB community and what we’re looking forward to seeing in London.

    Poništi
  13. proslijedio/la je Tweet

    The debra Care Conference is a great opportunity for guests to try wound care products, hear the latest in research, & meet with industry leaders. We're honored to facilitate the meeting place for advocates that are changing the course for EB. Reg for the 2020 DCC opens in Jan!

    Poništi
  14. 12. pro 2019.

    The 33rd Annual Family Conference takes place at Disney World from Dec.19-21. We hope to see you there! Check out the conference website for details:

    Poništi
  15. 10. pro 2019.

    As 2019 comes to a close, we reflect back on the incredible events we’ve taken part in on behalf the communities we serve. The patients, families & advocates we have met and the inspiring stories we've heard fuel our work each day. We're grateful for your support!

    Poništi
  16. 9. pro 2019.

    FDA has cleared us to begin a pivotal Phase 3 clinical trial evaluating our gene-corrected cell therapy for . The VIITAL™ study is expected to begin in 1Q20.

    Poništi
  17. proslijedio/la je Tweet

    . is developing a CPG on Neonatal Care in EB. Whether you're a parent, caregiver, family member, or member of the community who's been involved in the care of a baby with EB, your survey responses will directly affect the issues addressed:

    Prikaži ovu nit
    Poništi
  18. 20. stu 2019.

    EB2020 is coming up fast! We are looking forward to gathering with the community this January. Take a look at what you can expect at the inaugural global congress in London:

    Poništi
  19. 19. stu 2019.

    November is Month. We honor all those who care for someone living with a , including those in our patient communities impacted by , syndrome, and .

    Poništi
  20. 18. stu 2019.

    The newest patient education page from focuses on mucopolysaccharidoses () and the potential could offer to those living with certain types of . Learn more:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·